Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis
Molecules · 2025
DOI: 10.3390/molecules30244739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Liqing Zang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan. Hauptthemen laut MEDLINE: Erythropoietin, Anemia, Peptides, Milk. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rohto Pharmaceutical Co., Ltd..
Abstract (Originalsprache)
Anemia, characterized by reduced hemoglobin (Hb), remains a major health concern. Although iron and erythropoietin (EPO) therapies are effective, limitations in safety and accessibility have prompted interest in nutritional alternatives. Hydrolyzed milk-derived peptides (H-MDPs) contain bioactive sequences with diverse physiological effects, yet their role in erythropoiesis remains poorly defined. This study investigated the hematopoietic actions of H-MDP using zebrafish and mouse models. Adult zebrafish underwent phlebotomy-induced anemia and received oral H-MDP for 3 weeks. Hb levels, erythrocyte morphology, and expression of erythropoiesis- and iron-metabolism genes were assessed. In healthy mice, renal Epo expression, circulating EPO, and serum cytokines were measured after 2 weeks of H-MDP administration. H-MDP significantly accelerated Hb recovery in anemic zebrafish (4.6 ± 0.64 g/dL vs. 3.4 ± 0.66 g/dL in untreated fish at week 1) and markedly improved erythrocyte maturation. These effects coincided with strong induction of epo, hif1aa/b, igf1, csf1a, and csf3b in the heart and liver, as well as normalization of anemia-induced hepatic iron-transport genes (tfa, fpn1, tfr2) and reactivation of hamp. In mice, H-MDP elevated renal Epo mRNA and circulating EPO (approximately 2.3-fold) without altering steady-state Hb, and cytokine profiling with IPA-predicted activation of the erythropoietin signaling pathway. Collectively, these findings indicate that H-MDPs modulate erythropoiesis by coordinating the activation of EPO-related and iron-regulatory networks, supporting their potential as functional food ingredients for hematologic recovery and anemia management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.
- Mie University Zebrafish Research Center, Tsu 514-8507, Japan.
- Department of Integrative Pharmacology, Mie University Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.
- Rohto Pharmaceutical Co., Ltd., Osaka 544-8666, Japan.
ORCID-Profile: Liqing Zang, Norihiro Nishimura, Yasuhito Shimada
Förderung
- Rohto Pharmaceutical Co., Ltd.
Zitieren
APA
Zang, L., Yokota, A., Nakai, M., Fukada, K., Nishimura, N., & Shimada, Y. (2025). Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis. Molecules. https://doi.org/10.3390/molecules30244739
Vancouver
Zang L, Yokota A, Nakai M, Fukada K, Nishimura N, Shimada Y. Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis. Molecules. 2025. doi:10.3390/molecules30244739
BibTeX
@article{Zang2025,
author = {Zang, Liqing and Yokota, Akira and Nakai, Misa and Fukada, Kazutake and Nishimura, Norihiro and Shimada, Yasuhito},
title = {Hydrolyzed Milk-Derived Peptides Promote Erythropoietin Pathways and Hematologic Recovery: A Cross-Species Analysis},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30244739}
}
EUVIMED